Skip to main content

Table 2 Risk of bias assessment using the Cochran scoring method

From: The effects of conjugated linoleic acid supplementation on glycemic control, adipokines, cytokines, malondialdehyde and liver function enzymes in patients at risk of cardiovascular disease: a GRADE-assessed systematic review and dose–response meta-analysis

Study

Random sequence generation

Allocation concealment

Selective reporting

Other sources of bias

Blinding (participants and personnel)

Blinding (outcome assessment)

Incomplete outcome data

General risk of bias

RISerus et al. 2002 [44]

L

H

H

L

L

U

H

High

Moloney et al. 2004 [35]

L

H

H

L

L

U

L

Moderate

Naumann et al. 2006 [45]

L

H

H

L

L

U

L

Moderate

Schmitt et al. 2006 [46]

L

H

H

L

L

U

L

Moderate

Zhao et al. 2009 [36]

L

H

H

H

L

U

L

High

Norris et al. 2009 [42]

L

L

H

L

L

U

L

Low

Shadman et al. 2010 [37]

L

H

H

H

L

L

L

High

Joseph et al. 2011 [34]

L

H

H

H

L

U

H

High

Shadman et al. 2013 [38]

L

H

H

L

L

U

L

Moderate

Carvalho et al. 2013

L

H

H

H

L

U

L

High

Eftekhari et al. 2013 [41]

L

L

H

H

L

U

L

Moderate

Ebrahimi-Mameghani et al. 2016 [40]

L

L

H

L

L

L

L

Low

Abedi et al. 2018 [39]

L

L

H

L

H

H

L

High

  1. L Low risk of bias, H High risk of bias, U Unclear risk of bias
  2. General Low risk < 2 high risk
  3. General moderate risk = high risk
  4. General high risk > 2 high ris